Back to Agenda
[Session 1] Digital Health
Session Chair(s)
Akimitsu Ikeura, MSc
Associate Director, Data Management Group, Biostatistics & Data Management Dept.
Daiichi Sankyo Co., Ltd., Japan
Yukiko Nagata
Director, Biometrics
ICON Clinical Research GK, Japan
In recent years, in addition to traditional EDC, IWRS/IRT and EHR, newcomers such as ePRO, smart watches, and smart phones using dedicated applications, have built up the concept of eSource (compared to paper-based source) data. Utilization of “Digital Health” to comprehensively connect these technologies and ideas has attracted wide attention in the health care industry. Digital health can transform the workflow of pharmaceutical companies, CROs, vendors and academic researchers, and each organization is proactively starting on this new area. Its potential impact is expected to contribute significantly to drug discovery and Ikuyaku. Focusing on data reliability in this new era of progress – i.e., satisfying ERES requirements in compliance with the principle of ALCOA – this session will provide an enthusiastic discussion on: What is Digital Health? What benefit will Digital Health efforts provide to patients? To the health care industry? What should we carefully consider?
Speaker(s)
Machine Learning in Healthcare
Brian Forbes, PhD
Bayer Yakuhin, Ltd., Japan
Digital Health Leader, Advanced Analytics & Open Innovation Center
Digitalisation – a key approach to data collection
Puspita Roy, MSc
Nutricia Research, Singapore
Senior Data Manager
ePRO/COA experience at Lilly
Misato Kuwagaki, MS
Eli Lilly Japan K.K., Japan
Associate Director, Data Sciences
TransCelerate’s Lessons Learned on eSource in Clinical Trials
Brett Wilson
Pfizer Inc, Canada
Senior Director, Global Biometrics and Data Management
eSource Data: What Should be Carefully Considered?
Osamu Komiyama
Pfizer R&D Japan G.K., Japan
Senior Manager, Statistical Research & Data Science
Have an account?